Current Report Filing (8-k)

Date : 06/04/2019 @ 11:41AM
Source : Edgar (US Regulatory)
Stock : IMMUNIC INC (IMUX)
Quote : 13.55  0.41 (3.12%) @ 1:00AM
IMMUNIC INC share price Chart

Current Report Filing (8-k)

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 4, 2019

 

IMMUNIC, INC.


(Exact name of registrant as specified in its charter)

 

Delaware 001-36201 56-2358443
(State or other jurisdiction
of incorporation)
(Commission File Number) (IRS Employer Identification No.)
     
 

Am Klopferspitz 19

82152 Martinsried

Germany

 
  (Address of principal executive offices)  

 

Registrant’s telephone number, including area code: 49 89 250079460

 

Vital Therapies, Inc.

15222-B Avenue of Science

San Diego, CA 92128

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class Trading symbol(s)

Name of each exchange

on which registered

Common Stock, $0.0001 par value IMUX The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b2 of this chapter).

 

Emerging growth company ý

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes ý No ¨

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

On June 4, 2019, Immunic, Inc. (the “Company”) issued a press release with newly available preclinical data regarding IMU-935, one of the Company’s development programs. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. A poster presentation of the preclinical data is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

 

The information in Item 7.01 of this Current Report on Form 8-K and Exhibits 99.1 and 99.2 attached hereto are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor is it to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in any such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.

 

Exhibit Description

   
99.1   Press Release, dated June 4, 2019
99.2   Poster Presentation

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

     
Dated: June 4, 2019 Immunic, Inc.
     
  By: 

/s/ Daniel Vitt

    Daniel Vitt
    Chief Executive Officer

 

 

 

IMMUNIC INC (NASDAQ:IMUX)
Historical Stock Chart

1 Year : From Jul 2018 to Jul 2019

Click Here for more IMMUNIC INC Charts.

IMMUNIC INC (NASDAQ:IMUX)
Intraday Stock Chart

Today : Sunday 21 July 2019

Click Here for more IMMUNIC INC Charts.

Latest IMUX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20190721 16:53:54